STAAR Surgical Company announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to STAAR Surgical's President and CEO, Tom Frinzi. Most recently, Warren Foust served as Worldwide President, Johnson & Johnson Vision, Surgical, since December 2019.

At Johnson & Johnson, Warren managed the global surgical business with approximately $1.5 billion in annual sales and 5,000 employees. Prior to Johnson & Johnson Vision, Surgical, Warren served as Worldwide President of Mentor, a leading breast reconstruction and aesthetics business unit of Johnson & Johnson from 2018-2019, and Vice President, U.S. Sales and Marketing from 2015-2018. Prior to Mentor, Warren held various sales leadership roles at DePuy Synthes, also a company of Johnson & Johnson.

He started his career at Roche Pharmaceuticals as a sales representative in 1999. Warren holds an MBA and bachelor's degree from the University of Alabama. Magda Michna, Ph.D., joins STAAR Surgical from AcuFocus Inc. where she served as Chief Global Clinical, Medical and Regulatory Affairs Officer since April 2018.

AcuFocus was acquired by Bausch & Lomb in January 2023. Prior to AcuFocus, Dr. Michna served as Chief Clinical Officer at Presbia. From 2012 to 2017, Dr. Michna led clinical development for many premium intraocular lens and other surgical device technologies supporting the Alcon Surgical franchise.

Her industry career began as a Vision Scientist at VISTAKON, a division of Johnson & Johnson Vision from 2008-2012, which she joined following an academic Research Fellowship with the Vision Research Group at McGill University's Department of Ophthalmology from 2005-2008. Dr. Michna holds a Doctor of Philosophy degree in optical physics and a bachelor's degree from the University of Melbourne, Australia.